Rebecca Chu
About Rebecca Chu
Rebecca Chu is a Postbaccalaureate Fellow at the National Institutes of Health, where she has contributed to research on gene therapy techniques since 2021. She previously interned at Gilead Sciences and conducted undergraduate research at the University of California, Los Angeles, where she earned her Bachelor of Science in Molecular, Cell, and Developmental Biology.
Work at National Institutes of Health
Rebecca Chu has been employed as a Postbaccalaureate Fellow at the National Institutes of Health (NIH) since 2021. In this role, she has been involved in research within the Laboratory of John Tisdale, focusing on enhancing gene therapy techniques specifically for hemoglobinopathies. Her work contributes to ongoing projects aimed at improving the efficiency and efficacy of gene therapies for blood disorders, reflecting her commitment to advancing medical research.
Previous Experience at Gilead Sciences
Prior to her current role, Rebecca Chu worked as a Process Development and Technical Services Intern at Gilead Sciences in La Verne, California, for three months in 2019. During her internship, she gained practical experience in the biotechnology industry, which provided her with insights into process development and technical services in a professional setting.
Education and Expertise
Rebecca Chu earned her Bachelor of Science degree in Molecular, Cell, and Developmental Biology from the University of California, Los Angeles (UCLA). She attended UCLA from 2017 to 2021, where she developed a strong foundation in biological sciences. Her academic background supports her research endeavors in gene therapy and related fields.
Undergraduate Research Experience
During her time at UCLA, Rebecca Chu served as an Undergraduate Researcher from 2020 to 2021. This role allowed her to engage in hands-on research, further enhancing her skills and knowledge in molecular and cellular biology. Her research experience laid the groundwork for her subsequent work at the NIH.